A. Duca

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression

Ella Daly, Madhukar H. Trivedi, Adam Janik et al. · JAMA Psychiatry · 2019 · 759 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 88 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia

John M. Kane, Raymond Sanchez, Joan Zhao et al. · Journal of Medical Economics · 2013 · 48 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis

John M. Kane, Cathy Zhao, B. Johnson et al. · Journal of Medical Economics · 2014 · 48 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study

Timothy Peters-Strickland, Ross A. Baker, Robert D. McQuade et al. · Schizophrenia · 2015 · 14 citations · Full text

Medicine, Pharmacology, Psychiatry +17